2,291
Views
42
CrossRef citations to date
0
Altmetric
Short Report

Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases

, , , &
Pages 1413-1417 | Received 15 Dec 2014, Accepted 16 Feb 2015, Published online: 18 Jun 2015

References

  • Rubin SA, Plotkin SA. Mumps vaccine. In: Plotkin SA, Orenstein W, Offit PA, editors. Vaccines, 6th Edition. Elsevier, 2013. pp 419-46.
  • Hviid A1, Rubin S, Mühlemann K. Mumps. Lancet. 2008 Mar 15; 371(9616):932-44; http://dx.doi.org/10.1016/S0140-6736(08)60419-5
  • Centers for Disease Control and Prevention (CDC). Chapter 14: Mumps. In: Atkinson W, Wolfe C, Hamborsky J, editors. Epidemiology and Prevention of Vaccine-Preventable Diseases. 12th ed. Washington DC: Public Health Foundation; 2012. pp. 205-21.
  • Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, Hunt K, Finley CG, Leschinsky DP, O'Keefe AL, et al. Recent Resurgence of Mumps in the United States. N Engl J Med 2008;358(15):1580-9; PMID:18403766; http://dx.doi.org/10.1056/NEJMoa0706589
  • Slater PE, Anis E, Leventhal A. The control of mumps in Israel. Eur J Epidemiol 1999 Sep; 15(8):765-7.; http://dx.doi.org/10.1023/A:1007663429371
  • Ministry of Health, State of Israel, Israel Center for Disease Control (ICDC). Notifiable Infectious diseases in Israel: 60 y of surveillance, 1951-2010. 2012. Available at: www.health.gov.il/publicationsfiles/Disease1951_2010.pdf. Accessed 9/2014
  • Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, Cummings KP, Alleyne EO, High P, Lawler J, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med 2012 Nov;367(18):1704-13; http://dx.doi.org/10.1056/NEJMoa1202865
  • Stein-Zamir C, Shoob H, Abramson N, Tallen-Gozani E, Sokolov I, Zentner G. Mumps outbreak in Jerusalem affecting mainly male adolescents. EuroSurveill 2009 Dec 17; 14(50).
  • Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel's highly vaccinated society: are 2 doses enough? Epidemiol Infect 2012 Mar; 140(3):439-46; http://dx.doi.org/10.1017/S095026881100063X
  • Population of Israel and Jerusalem district by Population Group (table 2.10). In: Statistical abstract of Israel no.63. Jerusalem, Israel 2012. Available at: http://www.cbs.gov.il/
  • Levine H, Rishpon S, Huerta-Hartal M, Davidovitch N. Preventing mumps outbreaks in confined settings: comprehensive ring vaccination as a containment strategy. Hum Vaccin 2011 Dec;7(12):1389-93; http://dx.doi.org/10.4161/hv.7.12.18111
  • Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, Sirotkin B. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63(6):1055-68.
  • Kutty PK, Lawler J, Rausch-Phung E, Ortega-Sanchez IR, Goodell S, Schulte C, Pollock L, Valure B, Hudson J, Gallagher K, et al. Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010. Hum Vaccin Immunother 2014 May;10(5):1373-81; PMID:24633360; http://dx.doi.org/10.4161/hv.28389
  • Yung CF, Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis 2011; 17(4):661-7; PMID:21470456; http://dx.doi.org/10.3201/eid1704.101461
  • World Health Organization. Regional office for Europe. The centralized information system for infectious diseases (CISID). Mumps - Number of cases. Available in: http://data.euro.who.int/cisid/?TabID=361790
  • World Health Organization. Distribution of reported mumps genotypes, 2005-2011. Data as of 20 April 2012. Available in:http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/mumpsgenotype
  • Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, Duks A, Griskevicius A, Johansen K, Bartha K, et al. Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect 2013 Mar; 141(3):651-66.; http://dx.doi.org/10.1017/S0950268812001136
  • Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 2012 Feb 15; 2:CD004407
  • Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13(1):12-7; PMID:17370510; http://dx.doi.org/10.3201/eid1301.060649
  • Sane J, Gouma S, Koopmans M, de Melker H, Swaan C, van Binnendijk R, Hahné S. Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012. Emerg Infect Dis 2014 Apr; 20(4):643-8; http://dx.doi.org/10.3201/eid2004.131681
  • Takla A, Böhmer MM, Klinc C, Kurz N, Schaffer A, Stich H, Stöcker P, Wichmann O, Koch J. Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011. Hum Vaccin Immunother 2014 Jan;10(1):140-5; http://dx.doi.org/10.4161/hv.26642
  • Stein-Zamir C, Zentner G, Abramson N, Shoob H, Aboudy Y, Shulman L, Mendelson E. Measles outbreaks affecting children in Jewish ultra-Orthodox communities in Jerusalem. Epidemiol Infect 2008 Feb; 136(2):207-14.
  • Stein-Zamir C, Abramson N, Shoob H, Zentner G. An outbreak of measles in an ultra-Orthodox Jewish community in Jerusalem, Israel, 2007-an in-depth report. Euro Surveill 2008 Feb 21; 13(8) pii: 8045.
  • Stein-Zamir C, Shoob H, Abramson N, Zentner G. Who are the children at risk? Lessons learned from measles outbreaks. Epidemiol Infect. 2012 Sep; 140(9):1578-88; http://dx.doi.org/10.1017/S095026881100238X
  • Parker Fiebelkorn A, Rosen JB, Brown C, Zimmerman CM, Renshowitz H, D'Andrea C, Gallagher KM, Harpaz R, Zucker JR. Environmental factors potentially associated with mumps transmission in Yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009-2010. Hum Vaccin Immunother. 2013 Jan 1; 9(1):189-94; http://dx.doi.org/10.4161/hv.22415

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.